Half-year Report
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
Alpha Growth plc
Unaudited interim report for six month period ended
30 June 2024
The Board of Alpha Growth plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services specialist in life insurance-linked wealth and esoteric asset management, is pleased to announce its unaudited interim results for the six month period ended 30 June 2024.
Chairman's Statement
PERIOD ENDED 30 JUNE 2024
Key Highlights for the Period:
· Revenue Growth: Achieved a 12% increase in revenues compared to the same period last year.
· Significant move towards profitability: Reduced our loss before taxation to £0.14 million for the six months ended 30 June 2024, down from £0.42 million in the same period of 2023.
· Progress in Integration: Integration projects are starting to yield positive results, bringing the Group closer to achieving operating breakeven.
· Expansion and Innovation: Successfully enhanced assets within our insurance businesses and developed a new insurance product which is now ready for launch.
The Group is beginning to see the benefits of synergies across its diverse businesses and is excited to realize the full impact of our strategic initiatives as move forward. The Board is optimistic about achieving further substantial financial improvements and expects additional positive results from current projects, including the recent acquisition of Jeometri Insurance Managers (Guernsey) Limited, finalised in September 2024.
The Jeometri acquisition is expected to deliver significant opportunities for the Group, with the Jeometri team having already providing input in developing new products for Alpha International Life Assurance Company (Guernsey) Ltd ("AILAC"), which we anticipate will be highly attractive to the market.
We expect continued improvement in our cash flows and do not foresee the need for a share placement, unless it is for a strategic acquisition which will deliver material growth and which is significantly value and share price accretive.
Our buy-and-build strategy remains a priority and we are actively exploring additional acquisitions that complement and enhance our existing operations, and which will materially advance our plan to be managing over $2bn of AUM in 2025.
Whilst the Group has been advancing discussions with acquisition targets there can be no guarantee that these acquisitions will complete. The Directors however are confident that our existing strategy and value creation approach will ultimately be reflected in our share price.
I would like to express my gratitude to our shareholders for their continued support as we advance Alpha Growth into a leading organization in its sector.
Gobind Sahney
Chairman
17 September 2024
For more information, please visit www.algwplc.com or contact the following:
Alpha Growth plc | +44 (0) 20 3959 8600 |
Gobind Sahney, Executive Chairman | |
Allenby Capital Limited | +44 (0) 20 3328 5656 |
Amrit Nahal (Sales and Corporate Broking) | |
Nick Athanas / Piers Shimwell (Corporate Finance) | |
UK Investor Relations - Mark Treharne |
RESULTS FOR THE PERIOD
INTERIM PERIOD ENDED 30 June 2024
The results of the Group have been addressed above in the Chairman's statement.
Responsibility Statement
We confirm that to the best of our knowledge:
(a) the condensed set of financial statements has been prepared in accordance with IAS 34 'Interim Financial Reporting';
(b) the interim management report includes a fair review of the information required by DTR 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year; and
(c) the interim management report includes a fair review of the information required by DTR 4.2.8R (disclosure of related parties' transactions and changes therein).
CAUTIONARY STATEMENT
This Interim Management Report (IMR) has been prepared solely to provide additional information to shareholders to assess the Company's strategies and the potential for those strategies to succeed. The IMR should not be relied on by any other party or for any other purpose.
Going Concern
The Directors have a reasonable expectation that the Group has adequate resources to continue in operation or existence for the foreseeable future thus we continue to adopt the going concern basis in preparing these interim financial statements. As detailed in the Chairman's statement the on-going expected timing of transactions that the Company plans to be involved in and generate fees from, continue as planned and therefore should benefit the Group in the longer term.
PRINCIPAL RISKS AND UNCERTAINTIES
The principal risks and uncertainties affecting the business activities of the Group are detailed on page 15 and 16 of the Annual Report and Financial Statements for the year ended 31 December 2023, a copy of which is available on the Company website at www.algwplc.com. The Board considers that these remain a current reflection of the risks and uncertainties facing the business for the remaining six months of the financial year.
Gobind Sahney
Director
17 September 2024
Alpha Growth plc
CONSOLIDATED Statement of comprehensive income
INTERIM period ENDED 30 june 2024
(Unaudited) | (Unaudited) | (Audited) | ||
Six months | Six months | 12 months | ||
Ended | Ended | Ended | ||
30.6.2024 | 30.6.2023 | 31.12.2023 | ||
Notes | £ | £ | £ | |
Restated | ||||
Continuing operations |
| |||
Revenue from Owned Insurance Companies | 2,605,527 | 2,222,909 | 4,731,056 | |
Revenue from Contracts with Clients | 199,987 | 275,801 | 449,415 | |
Other income | 3,684 | 2,121 | 26,314 | |
| ||||
Total revenue |
| 2,809,198 | 2,500,831 | 5,206,785 |
Amortisation of intangible assets | (51,496) | (29,620) | (52,931) | |
Interest expense and investment costs | (3,959) | (15,095) | (21,422) | |
Expenses in managing owned insurance companies | (1,274,954) | (1,240,409) | (2,813,214) | |
Operating expenses | (1,622,239) | (1,637,643) | (3,810,655) | |
| ||||
(Loss) before taxation |
| (143,450) | (421,936) | (1,491,437) |
Taxation | 27,523 | 31,156 | 135,182 | |
| ||||
Loss for the period |
| (115,927) | (390,780) | (1,356,255) |
Other comprehensive income |
| |||
Items that may be reclassified subsequently to profit or loss: | ||||
Exchange differences on foreign operations | 18,734 | (76,650) | 10,436 | |
| ||||
Total comprehensive income |
| (97,193) | (467,430) | (1,345,819) |
Attributable to: | ||||
Owners of the Company | (97,193) | (456,850) | (1,335,239) | |
Non-controlling Interests | - | (10,580) | (10,580) | |
(97,193) | (467,430) | (1,345,819) | ||
Earnings / (loss) per share from continuing |
| |||
operations attributable to the equity owners |
| |||
Basic (loss)/earnings per share (pence) | 3 | (0.02p) | (0.1p) | (0.2p) |
Fully diluted (loss)/earnings per share (pence) | 3 | (0.02p) | (0.1p) | (0.2p) |
|
|
Alpha Growth plc
CONSOLIDATED Statement of Financial Position
AS AT 30 june 2024
(Unaudited) | (Unaudited) | (Audited) | ||
As at | As at | As at | ||
30.6.2024 | 30.6.2023 | 31.12.2023 | ||
£ | £ | £ | ||
Restated | ||||
Assets |
| |||
Cash and cash equivalents | 4,537,657 | 5,050,071 | 7,420,418 | |
Short term investments | 363,819 | 337,913 | 360,430 | |
Trade and other receivables | 2,245,220 | 4,297,140 | 13,928,139 | |
Loans to policyholders | 10,571,396 | 6,653,367 | 10,178,506 | |
Deferred tax asset | 659,004 | 521,539 | 617,887 | |
Right of use assets | - | - | 143,422 | |
Tangible fixed assets | 39,545 | - | ||
Intangible assets | 1,447,100 | 1,525,542 | 1,488,520 | |
| 19,863,741 | 18,385,570 | 34,137,322 | |
Assets backing unit-linked and contractual liabilities |
| |||
Cash and cash equivalents - assets backing | 2,328,343 | 8,460,707 | 10,950,357 | |
Financial assets | 450,034,659 | 417,550,206 | 423,770,659 | |
452,363,002 | 426,010,913 | 434,721,016 | ||
|
| |||
Total assets | 472,226,743 | 444,396,483 | 468,858,338 | |
Liabilities |
| |||
Trade and other payables | 896,303 | 2,003,032 | 5,375,795 | |
Income tax payable | - | 1,546 | - | |
Policy claims payable | 2,320,695 | 2,314,818 | 12,705,096 | |
Short term loans | 10,567,648 | 6,649,624 | 10,174,784 | |
Lease liabilities | 139,272 | 213,188 | 170,386 | |
Provisions | 325,753 | 431,808 | - | |
| 14,249,671 | 11,614,016 | 28,426,061 | |
Unit-linked and contractual liabilities |
| |||
Unit-linked liabilities | 445,259,848 | 418,919,671 | 427,809,449 | |
Structured settlements | 7,103,154 | 7,091,242 | 6,911,565 | |
452,363,002 | 426,010,913 | 434,721,014 | ||
|
| |||
Total liabilities | 466,612,673 | 437,624,929 | 463,147,075 | |
Net Assets | 5,614,070 | 6,771,554 | 5,711,263 | |
Total Equity | 5,614,070 | 6,771,554 | 5,711,263 |
Company number: 09734404
Alpha Growth plc
CONSOLIDATED Statement of Changes in Equity
INTERIM period ENDED 30 june 2024
Share |
| Share |
| Option |
| Share-based |
| Foreign |
| Retained |
| Total |
| Non- |
| Total | |
| Capital |
| Premium |
| Reserve |
| Payment |
| Exchange |
| Deficit |
| Attributable to |
| Controlling |
| |
Reserve |
| Reserve |
| Shareholders |
| Interests |
| ||||||||||
£ | £ | £ | £ | £ | £ | £ | £ | £ | |||||||||
AS AT 31 DECEMBER 2022 as previously reported | 431,887 |
| 5,388,152 |
| 815,474 |
| 113,390 |
| 182,748 |
| (505,314) |
| 6,426,337 |
| 282,098 |
| 6,708,435 |
Restatement to reflect elimination of insurance and reinsurance reserves | - | - | - | - | - | (85,420) | (85,420) | - | (85,420) | ||||||||
AS AT 31 DECEMBER 2022 restated | 431,887 |
| 5,388,152 |
| 815,474 |
| 113,390 |
| 182,748 |
| (590,734) |
| 6,340,917 |
| 282,098 |
| 6,623,015 |
Loss for the period | (380,200) | (380,200) | (10,580) | (390,780) | |||||||||||||
Foreign exchange gain on conversion of subsidiary | - | - | - | - | (57,891) | - | (57,891) | (18,759) | (76,650) | ||||||||
Total comprehensive income for the period | - | - | - | - | (57,891) | (380,200) | (438,091) | (29,339) | (467,430) | ||||||||
Shares issued | 35,888 | 860,810 | - | - | - | - | 896,698 | - | 896,698 | ||||||||
Employee share options expired | - | - | (145,526) | - | - | 145,526 | - | - | - | ||||||||
Exercise of warrrants | - | - | - | (113,390) | - | - | (113,390) | - | (113,390) | ||||||||
Acquisition of non-controlling interests | - | - | - | - | - | - | - | (252,759) | (252,759) | ||||||||
AS AT 30 JUNE 2023 | 467,775 |
| 6,248,962 |
| 669,948 |
| - |
| 124,857 |
| (825,408) |
| 6,686,134 |
| - |
| 6,686,134 |
Profit for the period | - | - | - | - | - | (965,475) | (965,475) | - | (965,475) | ||||||||
Foreign exchange loss on conversion of subsidiary | - | - | - | - | (9,396) | - | (9,396) | 96,482 | 87,086 | ||||||||
Total comprehensive income for the period | - | - | - | - | (9,396) | (965,475) | (974,871) | 96,482 | (878,389) | ||||||||
Employee share options expired | - | - | (8,035) | - | - | 8,035 | - | - | - | ||||||||
Acquisition of non-controlling interests | - | (96,482) | (96,482) | ||||||||||||||
AS AT 31 DECEMBER 2023 | 467,775 |
| 6,248,962 |
| 661,913 |
| - |
| 115,461 |
| (1,782,848) |
| 5,711,263 |
| - |
| 5,711,263 |
Loss for the period | - | - | - | - | - | (115,927) | (115,927) | - | (115,927) | ||||||||
Foreign exchange gain on conversion of subsidiary | - | - | - | - | 18,734 | - | 18,734 | - | 18,734 | ||||||||
Total comprehensive income for the period | - | - | - | - | 18,734 | (115,927) | (97,193) | - | (97,193) | ||||||||
AS AT 30 JUNE 2024 | 467,775 |
| 6,248,962 |
| 661,913 |
| - |
| 134,195 |
| (1,898,775) |
| 5,614,070 |
| - |
| 5,614,070 |
Alpha Growth plc
CONSOLIDATED Statement of Cash Flows
INTERIM PERIOD ENDED 30 june 2024
(Unaudited) | (Unaudited) | (Audited) | |
6 months | 6 months | 12 months | |
Ended | Ended | Ended | |
30.6.2024 | 30.6.2023 | 31.12.2023 | |
£ | £ | £ | |
Restated | |||
OPERATING ACTIVITIES |
| ||
Loss for the period before interest and taxation | (143,175) | (408,962) | (1,496,329) |
Adjusted for: | |||
Services settled by way of payment in shares/options | - | 108,816 | 108,816 |
Amortisation of intangible assets and right of use assets | 29,742 | 29,620 | 64,430 |
Gain on disposal of sublease | - | (45,156) | (147,805) |
Other non-cash movements | 365,533 | 40,068 | (451,301) |
Operating cash outflows before movements in working capital: | 252,100 | (275,614) | (1,922,189) |
(Increase)/decrease in trade and other receivables | 11,798,080 | 9,706,047 | (121,410) |
Increase/(decrease) in trade and other payables | (4,493,086) | (2,521,419) | 910,701 |
Increase/(decrease) in short term loans | (26) | 7,924 | 179 |
Increase/(decrease) in policy claims | (10,384,401) | (9,945,182) | 445,096 |
(Increase)/decrease in short term investments | (3,389) | 158 | (14,594) |
(Increase)/decrease in financial assets backing unit-linked liabilities | (26,264,000) | (3,503,242) | (9,723,695) |
Increase/(decrease) in unit linked liabilities and structured settlements | 17,641,988 | (5,494,242) | 3,215,859 |
| |||
Net cash used in operating activities | (11,452,734) | (12,025,570) | (7,210,053) |
| |||
FINANCING ACTIVITIES |
| ||
Repayment of leasing liabilities | (39,495) | (31,783) | (68,097) |
Sublease of premises including interest | 26,055 | 32,370 | 171,439 |
Interest paid on leasing liabilities and loans | - | - | (31,422) |
Purchase of fixed assets | (39,545) | - | - |
Loan finance | - | (300,000) | (350,000) |
Other interest received | 944 | - | 23,147 |
Net proceeds from issuance of shares net of issue costs | - | 344,390 | 344,390 |
| |||
Net cash (outflow)/inflow from financing activities | (52,041) | 44,977 | 89,457 |
Net (decrease)/increase in cash and cash equivalents | (11,504,775) | (11,980,593) | (7,120,596) |
Cash and cash equivalents at beginning of period | 18,370,775 | 25,491,371 | 25,491,371 |
| |||
Cash and cash equivalents at end of period | 6,866,000 | 13,510,778 | 18,370,775 |
Cash and cash equivalents at end of period consists of: |
| ||
Cash and cash equivalents presented within assets | 4,537,657 | 5,050,071 | 7,420,418 |
Cash and cash equivalents presented within assets backing unit-linked liabilities | 2,328,343 | 8,460,707 | 10,950,357 |
| |||
Cash and cash equivalents at end of period | 6,866,000 | 13,510,778 | 18,370,775 |
Alpha Growth plc
Notes to the Financial Statements
interim results to 30 june 2024
1. Organisation and Trading Activities
The company is incorporated and domiciled in England and Wales as a public limited company and operates from its registered office 35 Berkeley Square, Mayfair London, United Kingdom W1J 5BF.
The principal activity of the Group is the provision of advice and consultancy services to institutional investors and existing and prospective holders of Senior Life Settlements through the management of its funds and the ownership of life insurance companies.
2. Summary of Significant Accounting Policies
The principal accounting policies adopted and applied in the preparation of these interim Group Financial statements are set out below.
These have been consistently applied to all the periods presented unless otherwise stated:
Basis of accounting
These interim financial statements of Alpha Growth plc (the "Group") have been prepared in accordance with UK adopted international accounting standards ("UK-adopted IAS") applied in accordance with the provisions of the Companies Act 2006.
The interim financial statements have been prepared under the historical cost convention on the basis of the accounting policies as set out in the Group's audited annual financial statements and are presented in GBP £ the presentational and functional currency of the Group. The Group has applied IAS 34 in the preparation of these interim financial statements.
This announcement was approved and authorised by the Board of directors on 17 September 2024. Copies of this interim report will be made available on the Company's website at www.algwplc.com.
These condensed interim financial statements for the six months ended 30 June 2024 are unaudited and do not constitute fully prepared statutory accounts. The comparative figures for the 12 month period ended 31 December 2023 are extracted from the 2023 audited financial statements. The independent auditor's report on the 2023 financial statements contained disclaimer of opinion.
Going concern
Any consideration of the foreseeable future involves making a judgement, at a particular point in time, about future events which are inherently uncertain.
The Directors have a reasonable expectation that the Group has sufficient cash and liquid reserves in order to meet any future obligations and thus to continue operating for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the Financial Statements.
COMPARATIVE INFORMATION
The comparative information for the six month period to 30 June 2023 has been restated to make the information consistent with the audited financial statements for the year ended 31 December 2023. The restatement relates to the following areas:
· Disaggregation of assets and liabilities in insurance businesses - the Directors' decided to present information relating to the life assurance subsidiaries on a disaggregated basis, rather than reporting two separate line items comprising total assets in insurance businesses and total liabilities in insurance businesses.
· Restatement of sub-lease - the treatment of sub-lease has been amended to reflect the derecognition of the right of use asset and the recognition of an investment in sublease, in accordance with IFRS 16.
· Treatment of lapsed share options - share options with passed vesting dates, previously reversed out in the Statement of comprehensive income, were restated to remain recognised in equity with a corresponding transfer within equity from share based payment reserve to retained earnings. This treatment results in a fairer presentation of the services received from the directors.
3. EARNINGS / (LOSS) per Share
The basic earnings / (loss) per share is based on the loss for the period divided by the weighted average number of shares in issue during the year. The weighted average number of ordinary shares for the Company the period ended 30 June 2024 assumes that all shares have been included in the computation based on the weighted average number of days since issue. Since the Group has made a loss in the current and each of the prior periods, the warrants in issue are not dilutive.
30.6.2024 | 30.6.2023 | 31.12.2023 | |
£ | £ | £ | |
Loss for the period from continuing operations: | (115,927) | (292,432) | (1,356,255) |
Weighted average number of ordinary shares in issue for basic earnings | 467,775,068 | 447,084,823 | 458,046,069 |
Fully diluted average number of shares in issue | 467,775,068 | 447,084,823 | 458,046,069 |
Basic earnings per share | (0.02p) | (0.1p) | (0.2p) |
Fully diluted earnings per share | (0.02p) | (0.1p) | (0.2p) |
4. Share capital AND SHARE PREMIUM
Ordinary shares of £0.001 each | Share capital | Share premium | |
| Number | £ | £ |
| |||
At 1 January 2023 | 431,887,388 | 431,887 | 5,388,152 |
| |||
Warrant exercise | 18,750,000 | 18,750 | 469,640 |
Share issue as payment for services | 17,137,680 | 17,138 | 421,780 |
Costs related to warrant exercise | - | - | (30,610) |
At 30 December 2023 | 467,775,068 | 467,775 | 6,248,962 |
| |||
At 30 June 2024 | 467,775,068 | 467,775 | 6,248,962 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.